Rice, 52, who had been the company's top finance officer since 2006, is one of the most powerful black executives in corporate America. He had been widely considered a leading candidate to succeed CEO John Lechleiter, but that position went to fellow Lilly executive Dave Ricks.
Leigh Ann Pusey will join Eli Lilly and Co. next month as senior vice president for corporate affairs and communications.
Lilly is in a race with several pharmaceutical firms to develop migraine treatments using an approach known as anti-CGRP and that could create a multibillion-dollar market.
The lobby group, Pharmaceutical Research and Manufacturers of America—which counts Eli Lilly and Co. as a member—is proposing that to remain a member, companies will have to spend $200 million a year on research and development.
Oakland University in suburban Detroit on Thursday announced that its board of trustees unanimously chose Ora Hirsch Pescovitz for the job after a search involving more than 60 candidates.
The Indianapolis drugmaker is trying to reassure Wall Street that its pipeline is still poised to deliver.
Shares in Eli Lilly and Co. stock fell more than 3 percent Tuesday after the Indianapolis-based drugmaker released a quarterly earnings report that showed sales of potential blockbuster drug Jardiance missed expectations by a wide margin.
The Indianapolis-based drugmaker beat Wall Street expectations by 2 cents a share—performance it attributed to brisk sales of new products.
Eli Lilly and Co. told a federal jury that a German company is trying to take credit for centuries-old Chinese medicine in seeking royalties on the use of its erectile-dysfunction drug Cialis to treat an enlarged prostate.
The drug, which has the proposed brand name Olumiant and is approved for use in Europe, was expected to be a big seller.
Broadening its efforts to defuse outrage over skyrocketing prices, the pharmaceutical industry’s lobbying association has started an advertising campaign urging insurers to share with customers more of the benefits of rebates they’ve negotiated.
A sexual harassment scandal involving host Bill O’Reilly has prompted major advertisers such as Eli Lilly and Co. and several automakers to drop out. Indianapolis-based Angie’s List is among those sticking with the show.
Dave Ricks joined Lilly in 1996 and most recently served as president of Lilly Bio-Medicines. He took over as president and CEO on Jan. 1.
Taltz, which hit the market last year, is taking on an armful of older treatments, including creams, lotions, pills and injectables, such as Amgen’s Enbrel and AbbVie’s Humira.
Share of Eli Lilly and Co. and numerous other drug industry stocks fell Tuesday morning after the president sent a tweet promising to lower medicine costs for American people.
Getting elected mayor requires fine-tuned political instincts. Sometimes, those instincts say it’s time to leave a high-level job at the biggest company in town.
Alzheimer’s disease is rewriting the rules of drug discovery, with companies like Eli Lilly and others abandoning caution to keep pursuing an elusive hypothesis because the potential payoff is so great.
Eli Lilly and Co. said Bart Peterson, who served two terms as Indianapolis mayor, was stepping down as senior vice president "to pursue personal business interests" and expand his community volunteer commitments.
In Lilly’s partnership with Harvard Pilgrim Health Care, the not-for-profit insurer gets additional rebates if fewer patients using Lilly's diabetes treatment Trulicity meet blood sugar goals than expected.
Merck & Co. on Tuesday announced that it will end a study of its once-promising Alzheimer’s disease drug in patients with mild-to-moderate forms of the condition, just three months after Eli Lilly and Co. announced its own setback in a field that’s been littered with failures.
